GPCR Theme Editorial
G protein-coupled receptor hetero-dimerization : contribution to pharmacology and function
Triggering neurotrophic factor actions through adenosine A2A receptor activation : implications for neuroprotection
G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter
Role of G12 proteins in oncogenesis and metastasis
Regulation of RhoGEF proteins by G12/13-coupled receptors
cAMP signal transduction in the heart : understanding spatial control for the development of novel therapeutic strategies
β1- and β2-Adrenoceptor polymorphisms and cardiovascular diseases
EPAC proteins transduce diverse cellular actions of cAMP
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S
Prostanoid receptor antagonists : development strategies and therapeutic applications
Agonism and allosterism : the pharmacology of the free fatty acid receptors FFA2 and FFA3
Role of protein kinase C in functional selectivity for desensitization at the μ-opioid receptor : from pharmacological curiosity to therapeutic potential
Involvement of PKCα and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of μ-opioid receptors in mature brain neurons
Agonist efficacy and receptor desensitization : from partial truths to a fuller picture
Agonist-specific patterns of β2-adrenoceptor responses in human airway cells during prolonged exposure
On the mechanism of the persistent action of salmeterol : what is the current position?
Molecular mechanisms for the persistent bronchodilatory effect of the β2-adrenoceptor agonist salmeterol
Stimulation of cardiac β-adrenoceptors targets connexin 43
The signal transduction cascade regulating the expression of the gap junction protein connexin43 by β-adrenoceptors
The α1B/D-adrenoceptor knockout mouse permits isolation of the vascular α1A-adrenoceptor and elucidates its relationship to the other subtypes
Central antinociception induced by μ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB1 receptor
5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception
Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum
Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology
Role of α1- and β3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse
The long-acting β-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells
Pharmacogenetic characterization of indacaterol, a novel β2-adrenoceptor agonist
An estimation of β2-adrenoceptor reserve on human bronchial smooth muscle for some sympathomimetic bronchodilators
Cross-regulation between β1- and β3-adrenoceptors following chronic β-adrenergic stimulation in neonatal rat cardiomyocytes
Chronic adrenaline treatment fails to down-regulate the Del301–303-α2B-adrenoceptor in neuronal cells
SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor
Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts
Expression of distinct α1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits
Novel antagonists for proteinase-activated receptor 2 : inhibition of cellular and vascular responses in vitro and in vivo
Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat
Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242